The results revealed that levels of MMP-2 were robust in discriminating patients with lung cancer form benign diseases with an area under the curves (AUC) value of 0.7536 (95% CI, 0.6512–0.8561) (Figure 4A). This evidence concerns the gene MMP2 and lung carcinoma.